Global Ganja Report

Something of a corporate scramble is underway to secure patents for the various curative properties of CBD, and associated products and procedures. Pharmaceutical firms see a windfall, but some activists raise concerns about the creeping privatization of a cannabinoid that should belong to the genetic and intellectual commons of the human race. How realistic are fears about the imminent arrival of "corporate cannabis"?

With US stock exchanges still almost entirely closed to cannabis businesses, the stateside industry is increasingly seeking access to the Canadian exchanges in order to secure investment. Taking over publicly traded Canadian firms through reverse mergers has emerged as the critical tactic in this endeavor.

Arizona's top court issued a ruling hailed as a victory both for medicinal cannabis users and for the power of the state's voters to make law through the initiative process. The justices struck down a law banning possession of cannabis on college campuses even by those registered under the state medical marijuana program. In fact, the victory is limited—it doesn't mean students with medical marijuana cards can now light up on campus. But simple possession, at least, now cannot be prosecuted. 

In a still-murky scenario of rare federal enforcement against municipal corruption, FBI agents last week raided the home of the mayor of Adelanto in Southern California's San Bernardino county. In the same operation, a local cannabis dispensary was also searched. Economically troubled Adelanto has aggressively sought investment in its cannabis industry, but paranoia in the wake of the federal raids could have a chilling effect.

Around the world, mothers are on the frontlines of demanding legal access to cannabis products for their children who suffer from epilepsy and other ailments. Often, these courageous moms have risked their freedom to provide medicine for their offspring. Sometimes they have actually shamed the authorities into changing the law—but still face the prospect of prison time.

New York City's Cannabis Parade, flagship entry in the Global Marijuana March movement and a counterculture event dating back to the early 1970s, this year actually drew mainstream politicians and candidates. Nearly all struck themes of racial justice, emphasizing that a push for legalization in the Empire State must also address the social iniquities of cannabis prohibition and the "war on drugs."

A federal appeals court has turned down a challenge by the cannabis industry to the DEA's official finding that CBD is a controlled substance. But questions about whether CBD should be treated as a controlled substance remain pending at the state level.

Zimbabwe, seemingly an unlikely candidate, has just become the second African nation to legalize medical marijuana. The only other African country to have done so is the tiny landlocked mountain kingdom of Lesotho—where cannabis has long been tolerated as an economic mainstay. Given that Zimbabwe is traditionally one of Africa's more closed societies, this is a hopeful sign—both that things are loosening up there after the recent fall of its long-ruling strongman, and for an eventual daylighting of the dagga economy throughout the continent.